Literature DB >> 27562666

Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline.

Matheus Marcon1, Ana P Herrmann2, Ricieri Mocelin1, Cassiano L Rambo3, Gessi Koakoski4, Murilo S Abreu4, Greicy M M Conterato5, Luiza W Kist3, Maurício R Bogo3, Leila Zanatta1, Leonardo J G Barcellos4,6, Angelo L Piato7,8.   

Abstract

RATIONALE: Several model organisms have been employed to study the impacts of stress on biological systems. Different models of unpredictable chronic stress (UCS) have been established in rodents; however, these protocols are expensive, long-lasting, and require a large physical structure. Our group has recently reported an UCS protocol in zebrafish with several advantages compared to rodent models. We observed that UCS induced behavioral, biochemical, and molecular changes similar to those observed in depressed patients, supporting the translational relevance of the protocol.
OBJECTIVES: Considering that a pharmacological assessment is lacking in this zebrafish model, our aim was to evaluate the effects of anxiolytic (bromazepam) and antidepressant drugs (fluoxetine and nortriptyline) on behavioral (novel tank test), biochemical (whole-body cortisol), and molecular parameters (cox-2, tnf-α, il-6, and il-10 gene expression) in zebrafish subjected to UCS.
RESULTS: We replicated previous data showing that UCS induces behavioral and neuroendocrine alterations in zebrafish, and we show for the first time that anxiolytic and antidepressant drugs are able to prevent such effects. Furthermore, we extended the molecular characterization of the model, revealing that UCS increases expression of the pro-inflammatory markers cox-2 and il-6, which was also prevented by the drugs tested.
CONCLUSIONS: This study reinforces the use of zebrafish as a model organism to study the behavioral and physiological effects of stress. The UCS protocol may also serve as a screening tool for evaluating new drugs that can be used to treat psychiatric disorders with stress-related etiologies.

Entities:  

Keywords:  Antidepressants; Anxiolytics; Cortisol; Cytokines; Unpredictable chronic stress

Mesh:

Substances:

Year:  2016        PMID: 27562666     DOI: 10.1007/s00213-016-4408-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  74 in total

1.  Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats.

Authors:  Nathalie Castanon; Chantal Médina; Cécile Mormède; Robert Dantzer
Journal:  Psychoneuroendocrinology       Date:  2004-07       Impact factor: 4.905

Review 2.  Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants.

Authors:  Brian E Leonard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-11-02       Impact factor: 5.067

Review 3.  Serotonergic modulation of zebrafish behavior: towards a paradox.

Authors:  Anderson Manoel Herculano; Caio Maximino
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-03-28       Impact factor: 5.067

Review 4.  A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression.

Authors:  Harris A Eyre; Tracy Air; Simon Proctor; Sebastian Rositano; Bernhard T Baune
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-10-16       Impact factor: 5.067

Review 5.  Interaction between BDNF and serotonin: role in mood disorders.

Authors:  Keri Martinowich; Bai Lu
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

Review 6.  Mechanisms of stress in the brain.

Authors:  Bruce S McEwen; Nicole P Bowles; Jason D Gray; Matthew N Hill; Richard G Hunter; Ilia N Karatsoreos; Carla Nasca
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

Review 7.  Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment.

Authors:  Kenneth Belzer; Franklin R Schneier
Journal:  J Psychiatr Pract       Date:  2004-09       Impact factor: 1.325

8.  Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.

Authors:  Mounira Banasr; Gerald W Valentine; Xiao-Yuan Li; Shannon L Gourley; Jane R Taylor; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2007-06-21       Impact factor: 13.382

9.  Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder.

Authors:  Katja Beesdo; Daniel S Pine; Roselind Lieb; Hans-Ulrich Wittchen
Journal:  Arch Gen Psychiatry       Date:  2010-01

10.  Chronic unpredictable stress (CUS)-induced anxiety and related mood disorders in a zebrafish model: altered brain proteome profile implicates mitochondrial dysfunction.

Authors:  Sumana Chakravarty; Bommana R Reddy; Sreesha R Sudhakar; Sandeep Saxena; Tapatee Das; Vuppalapaty Meghah; Cherukuvada V Brahmendra Swamy; Arvind Kumar; Mohammed M Idris
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more
  23 in total

1.  Effects of N-acetylcysteine amide on anxiety and stress behavior in zebrafish.

Authors:  Carlos G Reis; Ricieri Mocelin; Radharani Benvenutti; Matheus Marcon; Adrieli Sachett; Ana P Herrmann; Elaine Elisabetsky; Angelo Piato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-11-25       Impact factor: 3.000

Review 2.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

3.  An Overview of Zebrafish Modeling Methods in Drug Discovery and Development.

Authors:  Bagher Larijani; Shayesteh Kokabi Hamidpour; Akram Tayanloo-Beik; Ainaz Shahbazbadr; Hanieh Yavari; Nazli Namazi; Mahmood Biglar; Babak Arjmand
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Expression pattern of cdkl5 during zebrafish early development: implications for use as model for atypical Rett syndrome.

Authors:  Marta Vitorino; Nídia Cunha; Natércia Conceição; M Leonor Cancela
Journal:  Mol Biol Rep       Date:  2018-05-11       Impact factor: 2.316

5.  Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling.

Authors:  Darya A Meshalkina; Elana V Kysil; Jason E Warnick; Konstantin A Demin; Allan V Kalueff
Journal:  Lab Anim (NY)       Date:  2017-10-06       Impact factor: 12.625

6.  A mixture of fipronil and fungicides induces alterations on behavioral and oxidative stress parameters in zebrafish.

Authors:  Fernanda Bevilaqua; Adrieli Sachett; Rafael Chitolina; Cristiane Garbinato; Henrique Gasparetto; Matheus Marcon; Ricieri Mocelin; Eliane Dallegrave; Greicy Conterato; Angelo Piato; Anna M Siebel
Journal:  Ecotoxicology       Date:  2019-12-21       Impact factor: 2.823

7.  Production of bioactive recombinant human fibroblast growth factor 12 using a new transient expression vector in E. coli and its neuroprotective effects.

Authors:  Mi Zhou; Jiangfei Chen; Kuikui Meng; Yu Zhang; Meng Zhang; Panyu Lu; Yongjun Feng; Mai Huang; Qiaoxiang Dong; Xiaokun Li; Haishan Tian
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-10       Impact factor: 4.813

8.  Anti-inflammatory properties of extracts from Chimonanthus nitens Oliv. leaf.

Authors:  Qi Sun; Jiajin Zhu; Feiwei Cao; Fengjia Chen
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

9.  Divergent effect of fluoxetine on the response to physical or chemical stressors in zebrafish.

Authors:  Murilo S Abreu; Ana Cristina V V Giacomini; Gessi Koakoski; Angelo L S Piato; Leonardo J G Barcellos
Journal:  PeerJ       Date:  2017-05-09       Impact factor: 2.984

Review 10.  Extracellular matrix remodeling with stress and depression: Studies in human, rodent and zebrafish models.

Authors:  Ismary Blanco; Katherine Conant
Journal:  Eur J Neurosci       Date:  2020-08-19       Impact factor: 3.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.